Widmer P S, Sonnenberg A, Koelz H R, Gazzaniga A, Brändli H, Blum A L
Arzneimittelforschung. 1979;29(1):148-50.
The bioavailability of the gastric secretory inhibitor 3-hydroxy-8-(p-phenylphenacyl)-1 alphaH, 5 alphaH-tropanium bromide (-)-tropate (ketoscilium, Ulcesium) is not affected by a single dose of an aluminum-magnesium antacid although binding occurs in vitro.
胃分泌抑制剂3-羟基-8-(对苯基苯甲酰)-1αH,5αH-托烷溴化物(-)-托品酸盐(凯托西利姆,乌尔斯西姆)的生物利用度不受单剂量铝镁抗酸剂的影响,尽管在体外会发生结合。